MeningoSphere Online

Tackling Meningococcal Threats

Course Aim

To equip healthcare professionals with comprehensive, up-to-date knowledge of meningococcal disease – from epidemiology and clinical presentation through to diagnosis, treatment, vaccination strategies and outbreak preparedness to enhance early recognition, optimize evidence-based clinical decision-making, and implement targeted preventive care within the Indian healthcare context.

Earn Your
Certificate

Secure Online
Access

Brain with Virus Illustration

Course Description

MeningoSphere is a self-paced online certification course developed for Indian healthcare professionals and delivered through the Engage platform. Across four expert-led modules totalling approximately 100 minutes of learning, the programme takes clinicians on a structured journey through the evolving landscape of meningococcal disease.

The course begins with the changing epidemiology of meningococcal disease globally and in India, including serogroup distribution, atypical presentations commonly missed in practice, and long-term complications. It then moves into diagnostic pathways – covering CSF analysis, PCR, neuroimaging and India-specific antibiotic protocols – supported by real-world case studies in paediatric and adult crisis management.

The course also addresses vaccination and prevention, including conjugate and protein-based vaccines, updated immunisation schedules, high-risk populations and strategies for tackling vaccine hesitancy. The programme concludes with outbreak control, public health response frameworks and future preparedness.

Each module includes an end-of-module assessment. Upon successful completion of all four assessments, participants receive a certificate of completion.

Learning Outcomes

By the end of this course, participants will:

  • Understand the global and Indian epidemiology of meningococcal disease, including serogroup distribution and burden of disease
  • Recognise the clinical spectrum of meningococcal disease across age groups, including atypical presentations commonly encountered in Indian practice
  • Identify the neurological, endocrine and psychological complications and long-term sequelae of meningococcal infections across age groups
  • Apply appropriate diagnostic pathways including CSF analysis, Gram stain, PCR and neuroimaging for acute bacterial meningitis
  • Select empiric and targeted antibiotic therapy using India-specific protocols aligned with international guidelines
  • Demonstrate awareness of current conjugate and protein-based meningococcal vaccines and their place in updated immunisation schedules
  • Manage chemoprophylaxis for contacts and vaccination in high-risk populations
  • Address barriers to vaccine uptake, including hesitancy, access and cost considerations
  • Understand the principles of meningococcal outbreak response and the roles of key stakeholders
  • Apply knowledge to post-acute monitoring, neurological follow-up and long-term patient care

Education & Professional Development Team

Adhitya Srinivasan

Dr. Balaji Chinnasami

MBBS, MD (Paediatrics), PG Diploma in Health Science and Adolescent Health Care,

Adhitya Srinivasan

Prof. Dr. Omesh Khurana

MBBS, MD- Paediatrics, Professor of Paediatrics and an Ex-Professor at CCM Government Medical College,

Adhitya Srinivasan

Dr. Anurag Singh

MBBS, MD (Paediatrics), Consultant Paediatrician and Neonatal Specialist based in Jodhpur.

Assess • Learn • Get Certified

Inside The Meningosphere Programme

Module 1

45 Min
Meningococcal Disease – What’s Changing?

8 Chapters

  • Introduction to Meningococcal Disease: Definition and Historical Perspective
  • Global Burden vs. Indian Epidemiology: What the Numbers Reveal
  • Pathophysiology of Meningococcitis: From Colonization to Crisis
  • Understanding Serogroups A,C,Y,W,B and others in Indian Context
  • Clinical Spectrum of Meningococcal Disease Across Age Groups
  • Atypical Presentations in Indian Practice: Misdiagnosis and Missed Signs
  • Complications of Meningococcitis: Neurologic, Endocrine, and Psychological Sequelae
  • Assessment Module 1

Module 2

45 Min
Diagnosis and Treatment – From Suspicion to Stabilization

8 Chapters

  • Cracking the Case: Diagnostic Pathways for Acute Bacterial Meningitis
  • Diagnostic Tools: CSF Analysis, Gram Stain, PCR, and Newer Technologies
  • Neuroimaging and Differential Diagnosis in CNS Infections
  • Empiric vs. Targeted Therapy: India-Specific Antibiotic Protocols
  • First 60 Minutes: Emergency Diagnostic and Treatment Flowchart
  • From Triage to Recovery: Managing Meningococcal Sepsis and Shock in Real Time
  • Case Studies in Indian Practice: Pediatric and Adult Crisis Management
  • Assessment Module 2

Module 3

45 Min
Vaccination & Prevention – What’s New, What’s Needed?

8 Chapters

  • New Frontiers in Prevention: The Science Behind Conjugate and Protein-Based Vaccines
  • Right Vaccine, Right Time: Navigating the Updated Immunization Schedules
  • Barriers to Vaccine Uptake in India: Access, Hesitancy, and Cost
  • Chemoprophylaxis for Contacts: Agents, Dosing, and Contraindications
  • Vaccination in High-Risk Populations: Asplenia, HIV, Travel, and Outbreak Settings
  • Meningococcal Vaccine Comparison Chart: A Clinical Cheat Sheet
  • Vaccine hesitancy, Advocacy and Acceptance
  • Assessment Module 3

Module 4

45 Min
Outbreak Control, Public Health & Future Preparedness

7 Chapters

  • Post-Acute Monitoring and Neurological Follow-Up
  • Long-Term Sequelae and Quality of Life After Recovery
  • Case study-Understanding Waterhouse-Friderichsen Syndrome: A Silent Killer
  • Meningococcal Outbreak Response: Who Does What, When
  • Strengethening of vaccine strategies and role of HCPs
  • Public Health Awareness & The Way Forward
  • Assessment Module 4

Meningococcal Disease – What’s Changing?
  • Introduction to Meningococcal Disease: Definition and Historical Perspective
  • Global Burden vs. Indian Epidemiology: What the Numbers Reveal
  • Pathophysiology of Meningococcitis: From Colonization to Crisis
  • Understanding Serogroups A,C,Y,W,B and others in Indian Context
  • Clinical Spectrum of Meningococcal Disease Across Age Groups
  • Atypical Presentations in Indian Practice: Misdiagnosis and Missed Signs
  • Complications of Meningococcitis: Neurologic, Endocrine, and Psychological Sequelae

Diagnosis and Treatment – From Suspicion to Stabilization
  • Cracking the Case: Diagnostic Pathways for Acute Bacterial Meningitis
  • Diagnostic Tools: CSF Analysis, Gram Stain, PCR, and Newer Technologies
  • Neuroimaging and Differential Diagnosis in CNS Infections
  • Empiric vs. Targeted Therapy: India-Specific Antibiotic Protocols
  • First 60 Minutes: Emergency Diagnostic and Treatment Flowchart
  • From Triage to Recovery: Managing Meningococcal Sepsis and Shock in Real Time
  • Case Studies in Indian Practice: Pediatric and Adult Crisis Management

Vaccination & Prevention – What’s New, What’s Needed?
  • New Frontiers in Prevention: The Science Behind Conjugate and Protein-Based Vaccines
  • Right Vaccine, Right Time: Navigating the Updated Immunization Schedules
  • Barriers to Vaccine Uptake in India: Access, Hesitancy, and Cost
  • Chemoprophylaxis for Contacts: Agents, Dosing, and Contraindications
  • Vaccination in High-Risk Populations: Asplenia, HIV, Travel, and Outbreak Settings
  • Meningococcal Vaccine Comparison Chart: A Clinical Cheat Sheet
  • Vaccine hesitancy, Advocacy and Acceptance

Outbreak Control, Public Health & Future Preparedness
  • Post-Acute Monitoring and Neurological Follow-Up
  • Long-Term Sequelae and Quality of Life After Recovery
  • Case study-Understanding Waterhouse-Friderichsen Syndrome: A Silent Killer
  • Meningococcal Outbreak Response: Who Does What, When
  • Strengethening of vaccine strategies and role of HCPs
  • Public Health Awareness & The Way Forward
 

Course Requirements

To participate in this online course, you will need:

  • A Windows or Mac computer (laptop, desktop or tablet)
  • A reliable internet connection
  • A modern web browser (Chrome, Firefox, Safari or Edge)
  • A valid Access ID provided at the time of registration

No prior specialist knowledge of meningococcal disease is required, though a clinical background is assumed.

Target Audience

  • Paediatrician